Treatment and Outcomes of Stage III Colon Cancer in Patients 80 Years of Age and Older

August 24, 2020 updated by: Registre des Tumeurs Digestives du Finistère
The objective of this study was to assess survival trends in elderly patients with stage III colon cancer

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

This retrospective population-based study included patients aged 80 years and older with stage III colon adenocarcinoma who underwent surgery between 2007 and 2014.

Study Type

Observational

Enrollment (Actual)

308

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
      • Brest, France, 29200
        • Registre de tumeurs digestives du Finistère

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

80 years and older (OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

clinical data

Description

Inclusion Criteria:

• Stage 3 colon adenocarcinoma

Exclusion Criteria:

  • Rectal tumors
  • Patients receiving neo-adjuvant chemotherapy or radiotherapy
  • Tumours of the appendix
  • Tumours with histology other than adenocarcinoma

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Stage 3 with adjuvant chemotherapy
Other: observational
observational
Stage 3 without adjuvant chemotherapy
Other: observational
observational

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Overall survival
Time Frame: 2007-2014
months
2007-2014

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Registre des Tumeurs Digestives du Finistère

Investigators

  • Study Chair: Michel Robaskiewicz, MD PhD, REGISTRE DES TUMEURS DIGESTIVES DU FINISTERE

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 1, 2018

Primary Completion (ACTUAL)

January 1, 2020

Study Completion (ACTUAL)

July 1, 2020

Study Registration Dates

First Submitted

August 15, 2020

First Submitted That Met QC Criteria

August 24, 2020

First Posted (ACTUAL)

August 25, 2020

Study Record Updates

Last Update Posted (ACTUAL)

August 25, 2020

Last Update Submitted That Met QC Criteria

August 24, 2020

Last Verified

August 1, 2020

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 908270

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Colon Adenocarcinoma

Clinical Trials on observational

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malta

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe